Latest News for APM
NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Instant NanoBiosensors Co., Ltd.…
Aptorum Group Limited (NASDAQ: APM - Get Free Report) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 2,681 shares, a decline of 75.1% from the December 15th total of 10,748 shares. Currently, 0.1% of the company's stock are short sold. Based on an
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for APM.
Senate Trading
No Senate trades found for APM.
U.S. House Trading
No House trades found for APM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.